Dr  Jonathan Paul

Dr Jonathan Paul

Senior Research Fellow

School of Medicine and Public Health (Reproductive Medicine)

Targeting better outcomes for mothers and babies

A leader in the field of reproductive medicine, Dr Jonathan Paul is internationally recognised for his work on targeting therapeutic nanoparticles to the muscle cells of the uterus.

Dr Jonathan Paul

The Delivery Suite

Dr Jonathan Paul is a Senior Research Fellow within a multidisciplinary team of researchers at the University of Newcastle’s Mothers and Babies Research Program (MBRP). Based within the Hunter Medical Research Institute (HMRI), MBRP researchers work to determine the cause, and most effective therapeutic approach, to maternal, fetal, and neonatal health problems in humans.

As Leader of the Myometrial Research Group and the Reproductive Nanomedicine Program, Jonathan is applying his expertise to a new mode of medication delivery to the uterus, which has the potential to radically decrease risks related to childbirth.

Jonathan’s revolutionary drug delivery vector has the capacity to target therapeutics specifically to the muscle cells of the pregnant uterus, which improves drug effectiveness while simultaneously improving patient safety. The revolutionary approach opens up new avenues for therapeutic intervention during pregnancy, potentially resulting in: halting preterm labour, inducing or accelerating non-productive labour, or stemming postpartum bleeding.

The unique system has garnered Jonathan much attention due to the potential to save countless lives before, during and after childbirth. In early 2015, Jonathan was awarded the President’s New Investigator Award by The Society for Reproductive Investigation at their 62nd Annual Meeting in San Francisco.

The Cell Express

Jonathan completed his PhD as a member of the Reproductive Science Group at the University of Newcastle, focusing on proteins expressed on the surface of ova and their relevance to sperm-ova interaction.

Jonathan then joined the Mothers and Babies team to undertake analyses of the gene expression and protein changes that occur during the transition of uterine muscle cells from a non-contractile to a contractile state. His skills in the lab have secured his involvement in many projects within the program.

The uterus is one of the organs in the body that is made of smooth muscle. Currently, medications administered to stimulate or relax the uterus have been designed for use in other areas of the body. As such, they can have off-target effects, limiting both the range of drugs that can be administered safely and the effectiveness of those chosen drugs.

Jonathan’s new system targets a particular protein, ensuring the medication is directed specifically to the uterus.

Nanoparticles on Target

Targeted lipid-based nanoparticles (tiny bubbles made from the same material as a cell membrane) deliver the medication by seeking out specific proteins. Jonathan explains:

“Our cells are surrounded by a membrane made of lipids. We use similar lipids to make tiny (nano-scale) spheres that encapsulate drugs and other therapies inside that sphere, then we target that sphere to the uterus.”

“What we have done is identified a particular protein that is expressed in high abundance on uterine muscle cells during pregnancy.  We’ve then targeted the nanoparticles to that protein.”

This targeted delivery system has the following benefits: it increases the effectiveness of existing medication; and offers the possibility of utilising drugs previously considered unsafe due to effects on other organs and tissues.

Working in collaboration with the MBRP Director, Distinguished Laureate Professor Roger Smith, Jonathan has adapted uterine-targeted nanomedicines for the delivery of nucleic acids, which are a new class of therapeutics with almost limitless potential.

Addressing Unmet Needs

Complications related to childbirth create considerable short- and long-term strains on mother and baby, as well as the health care system. There are several stages of pregnancy and labour that present a danger, especially in less developed countries.

Preterm birth is the worldwide leading cause of neonatal morbidity and mortality, accounting for ~75% of perinatal deaths and >50% of long-term infant disease. Prematurity affects ~15 million pregnancies annually, leading to an estimated 1 million deaths per year. Babies who survive being born preterm are at increased risk of short- and long-term morbidities. Short-term morbidities include breathing disorders, brain bleeding, bowel tissue death and heart defects, while long-term morbidities include cerebral palsy (responsible for >50% of cases), mental retardation, diabetes, cardiovascular, renal and eye disease, asthma, cancer, depression, autism, anxiety, and more.

If a pregnancy approaches 42 weeks a caesarean section will be performed to counter the increased risk of intrauterine death. This resource-intensive procedure may discourage the mother from giving birth naturally in future deliveries. In less developed countries, a c-section may not be an option.

If the uterus fails to contract following delivery, post-partum haemorrhage may result. In less developed countries, where there is limited or no access to medicines such as oxytocin (which promotes contractions and the restriction of blood vessels), excessive blood loss can result in death.

Using the targeted drug delivery system, nanoparticles could be filled with medication aimed at maximising uterine contraction, thus restricting the body’s ability to lose blood. When a pregnancy has continued past 42 weeks, the nanoparticles could be loaded with medication aimed at stimulating or increasing contractility. If preterm labour has begun, the nanoparticles would be loaded with medication to halt contractions.

Progressing to Term

Jonathan has achieved great success developing the delivery system using uterine tissue biopsied from pregnant giving birth via caesarean section, as well as in preclinical (mouse) models of preterm birth.

A major cause of preterm labour in women is inflammation. Accordingly, inflammation is being simulated to test how effectively the targeted delivery system can work to halt contractions when preterm labour occurs due to inflammation.

Progesterone withdrawal is another leading cause of preterm labour, as it is essential to the maintenance of a pregnancy. Further research will be undertaken using a mouse model to measure the efficacy of the targeted delivery system in the event of withdrawal of progesterone.

“Initially, we commenced by delivering tocolytics, which are drugs that block the contractile machinery of the uterine smooth muscle cells. This works great, but now we are also delivering nucleic acid therapies that are designed to reprogram the smooth muscle cells to a relaxed state,” says Jonathan.

Assuming the success of the mouse model trials, the next step would be to test the efficacy of the system using a primate model. Jonathan hopes to eventually work in collaboration with the University of Washington’s Infant Primate Research Laboratory within their Centre on Human Development and Disability.

Small but Versatile

It is already clear that the drug delivery vector could be adapted to target cells in other areas of the body.

You could target any number of tissues, provided each tissue has a specific marker. In this case, we have used it to target the uterus, but it certainly has a much broader scope than that,” Jonathan explains.

“If you have a cancer, for instance, that expresses a particular protein in high abundance relative to any other tissues or organs, then you could target drug-loaded nanoparticles to the cancer cells.”

Whether the targeted nanoparticles are stopping preterm labour or attacking cancer cells, this new system has the potential to save countless lives and revolutionise the way therapeutics are delivered.

Dr Jonathan Paul

Targeting better outcomes for mothers and babies

A leader in the field of reproductive medicine, Doctor Jonathan Paul is internationally recognised for his work on targeting therapeutic nanoparticles to the muscle cells of the uterus.

Read more

Career Summary

Biography

Dr Jonathan W. Paul (PhD, BBiotech (Hons. 1)) is Co-Director of the Mothers and Babies Research Program (MBRP), based within the Hunter Medical Research Institute (HMRI). As MBRP Co-Director, Dr Paul oversees the strategic objectives, research directions, and governance of the MBRP.

In addition to Co-Directing broader MBRP operations, Dr Paul leads the Myometrial Research Group and the Reproductive Nanomedicine Program within the MBRP. His research has the overarching goal of ensuring all babies are born at the ideal time and weight to help ensure a healthy start to life. In particular, Dr Paul’s research focuses on advancing our understanding of the mechanisms that trigger the onset of spontaneous premature uterine contractions, leading to preterm birth, and on the development of novel intervention strategies for preventing spontaneous preterm birth. To that end, Dr Paul has been awarded major grants from the NHMRC and NSW Ministry of Health supporting the development of nanoparticle-based strategies for achieving uterine-targeted delivery of therapeutics, including contraction-blocking drugs, regulators of inflammatory signalling, and nucleic acid therapeutics. 

Dr Paul’s research has attracted >$5M in funding. He is Chief Investigator A on 3 concurrent major research grants, including a 2023–2025 NHMRC Ideas grant ($538,020), a 2022–2024 NHMRC Ideas grant ($732,334), and a 2021 – 2023 NSW Health Early-Mid Career Researcher Grant ($375,278). Dr Paul is also co-CI on a major 2023–2027 Hunter Medical Research Institute (HMRI) Philanthropy grant ($1,125,000) and a 2021–2024 NSW Health Gene and Cell Therapy PhD Scholarship ($80,000; Principal Supervisor), totalling $2.85M in current major funding. 
Dr Paul has translated this funding into significant scientific advances and international patents that have been recognised by the international scientific community for their potential to lead to improved preterm birth prevention therapies. 
Dr Paul’s research is internationally recognised. He has been an Invited Speaker for The International Preterm Birth Therapeutics Symposium 2023 (Brisbane), The Perinatal Society for Australia and New Zealand (PSANZ) 2023 (Melbourne), The International Conference on Emerging Advanced Nanomaterials 2022 (Newcastle), The Society for Reproductive Investigation 2021 (Boston), The International Conference on Emerging Advanced Nanomaterials 2020 (Newcastle), The Society for Reproductive Investigation 2020 (Vancouver), the Society of Maternal-Fetal Medicine 2019 (Las Vegas), the Mercy Perinatal Australian Reproduction Update 2018 (Melbourne), the Australian Society for Medical Research 2018 (Newcastle), and the Society for Reproductive Biology 2017 (Perth).


Qualifications

  • PhD (Biological Science), University of Newcastle
  • Bachelor of Biotechnology, University of Newcastle
  • Bachelor of Biotechnology (Honours), University of Newcastle

Keywords

  • labour
  • myometrium
  • nanomedicine
  • pregnancy
  • preterm birth
  • proteomics
  • reproductive medicine
  • smooth muscle contraction
  • targeted drug delivery

Fields of Research

Code Description Percentage
320599 Medical biochemistry and metabolomics not elsewhere classified 40
321599 Reproductive medicine not elsewhere classified 60

Professional Experience

UON Appointment

Title Organisation / Department
Senior Research Fellow University of Newcastle
School of Medicine and Public Health
Australia

Awards

Award

Year Award
2015 The Presidential New Investigator Award
Society of Reproductive Investigation
2001 Don Angus Memorial Award
The University of Newcastle - Faculty of Science and IT

Patents

Number Title Patent Family Registered Approved
WO 2014186843 A1 Targeted delivery of drugs to the myometrium
A mechanism for achieving the targeted delivery of therapeutic agents to the pregnant uterus, whether for the enhancement of uterine contractions or for the inhibition of uterine contractions. 
Standard 23/5/2014 2014

Prestigious works / other achievements

Year Commenced Year Finished Prestigious work / other achievement Role
2015 2015 HMRI Thru The Lens: A Culture for Success Hunter Medical Research Institute Artist
2015 2015 Video Publication: The Heart is Like an Orchestra, the Uterus is Like a Soccer Crowd Online Designer
2014 2014 ABC OPEN: Snapped at Work abc.net.au Artist
2014 2014 HMRI Through the Video Lens: Come Science With Me Hunter Medical Research Institute Creator
2013 2013 HMRI Thru The Lens: Cloning at HMRI Hunter Medical Research Institute Artist
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Chapter (4 outputs)

Year Citation Altmetrics Link
2020 Phung J, Paul J, Smith R, 'Maintenance of Pregnancy and Parturition', Maternal-Fetal and Neonatal Endocrinology, Elsevier., Philadelphia, PA, USA 169-187 (2020) [B1]
DOI 10.1016/B978-0-12-814823-5.00013-1
Citations Scopus - 3
Co-authors Roger Smith
2018 Ilicic M, Paul JW, 'Methods and model systems used to study pregnant human uterine smooth muscle', Muscle Cell and Tissue, InTechOpen, London, UK 309-335 (2018) [B1]
DOI 10.5772/intechopen.75201
Co-authors Marina Paul
2013 Smith R, Paul J, Chan C, Keelan J, 'The role of the primate placenta in term and preterm parturition', The Placenta: Development, Function and Diseases, Nova Science, Hauppaugue, NY 335-346 (2013) [B1]
Co-authors Roger Smith
2012 Schjenken JE, Tolosa Gonzalez JM, Paul JW, Clifton VL, Smith R, 'Mechanisms of maternal immune tolerance during pregnancy', Recent Advances in Research on the Human Placenta, InTech, Rijeka, Croatia 211-242 (2012) [B1]
Co-authors Roger Smith, John Schjenken
Show 1 more chapter

Journal article (46 outputs)

Year Citation Altmetrics Link
2024 Paul M, Barreda AP, Gregson A, Kahl R, King M, Hussein WM, et al., 'Regulation of 20a-Hydroxysteroid Dehydrogenase Expression in Term Pregnant Human Myometrium Ex Vivo.', Reprod Sci, 31 150-161 (2024) [C1]
DOI 10.1007/s43032-023-01333-6
Co-authors Roger Smith, Rohan Walker, Marina Paul
2023 Paul M, Paul JW, Hinwood M, Hood RJ, Martin K, Abdolhoseini M, et al., 'Clopidogrel Administration Impairs Post-Stroke Learning and Memory Recovery in Mice', International Journal of Molecular Sciences, 24 11706-11706 [C1]
DOI 10.3390/ijms241411706
Citations Scopus - 1
Co-authors Rohan Walker, Michael Nilsson, Marina Paul, Madeleine Hinwood, Rebecca Hood, Mahmoud Abdolhoseini, Sarah Johnson
2023 Hossain MR, Tolosa JM, Young RC, Smith R, Paul JW, 'Assessing the Potency of the Novel Tocolytics 2-APB, Glycyl-H-1152, and HC-067047 in Pregnant Human Myometrium.', Reprod Sci, 30 203-220 (2023) [C1]
DOI 10.1007/s43032-022-01000-2
Co-authors Roger Smith, Mdreduanul Hossain
2023 Paul M, Zakar T, Phung J, Gregson A, Barreda AP, Butler TA, et al., '20a-Hydroxysteroid Dehydrogenase Expression in the Human Myometrium at Term and Preterm Birth: Relationships to Fetal Sex and Maternal Body Mass Index.', Reprod Sci, 30 2512-2523 (2023) [C1]
DOI 10.1007/s43032-023-01183-2
Citations Scopus - 1
Co-authors Marina Paul, Rohan Walker, Craig Pennell, Roger Smith
2023 Phung J, Wang C, Reeders J, Zakar T, Paul JW, Tyagi S, et al., 'Preterm labor with and without chorioamnionitis is associated with activation of myometrial inflammatory networks: a comprehensive transcriptomic analysis', AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 228 (2023) [C1]
DOI 10.1016/j.ajog.2022.08.036
Citations Scopus - 1Web of Science - 1
Co-authors Craig Pennell, Roger Smith
2022 Dudley JS, Paul JW, Teh V, Mackenzie TE, Butler TA, Tolosa JM, et al., 'Seahorse brood pouch morphology and control of male parturition in Hippocampus abdominalis', Placenta, 127 88-94 (2022) [C1]

Introduction: Syngnathids (seahorses, pipefishes and seadragons) are among the few vertebrates that display male pregnancy. During seahorse pregnancy, males incubate developing em... [more]

Introduction: Syngnathids (seahorses, pipefishes and seadragons) are among the few vertebrates that display male pregnancy. During seahorse pregnancy, males incubate developing embryos embedded in a placenta within a fleshy brood pouch, before expelling fully developed neonates at parturition. The mechanisms underpinning seahorse parturition are poorly understood. Methods: We examined the morphology of the brood pouch using microcomputed tomography and histological techniques, in combination with physiological assays, to examine how male pot-bellied seahorses (Hippocampus abdominalis) control labour. In female-pregnant vertebrates, nonapeptide hormones (such as vasopressin- and oxytocin-like hormones) produce contractions of gestational smooth muscle to produce labour. Results: Histological analysis of the seahorse brood pouch reveals only scattered small smooth muscle bundles in the brood pouch, and in-vitro application of isotocin (a teleost nonapeptide hormone) to the brood pouch do not produce measurable muscle contractions. Micro-computed tomography shows differences in size and orientation of the anal fin assembly between male and female pot-bellied seahorses, and histological analysis reveals large skeletal muscle bundles attached to the anal fin bones at the male brood pouch opening. Discussion: We conclude that seahorse parturition may be facilitated by contraction of these muscles, which, in combination with body movements, serves to gape open the pouch and expel the neonates. Future biomechanical studies are needed to test this hypothesis.

DOI 10.1016/j.placenta.2022.07.015
Citations Scopus - 2
Co-authors Roger Smith
2022 Phung J, Wang CA, Reeders J, Chan EC, Riveros C, Zakar T, et al., 'Preterm labor is a distinct process from term labor following computational analysis of human myometrium', American Journal of Obstetrics and Gynecology, 226 106.e1-106.e16 (2022) [C1]

Background: The onset of the term human parturition involves myometrial gene expression changes to transform the uterus from a quiescent to a contractile phenotype. It is uncertai... [more]

Background: The onset of the term human parturition involves myometrial gene expression changes to transform the uterus from a quiescent to a contractile phenotype. It is uncertain whether the same changes occur in the uterus during preterm labor. Objective: This study aimed to compare the myometrial gene expression between term and preterm labor and to determine whether the presence of acute clinical chorioamnionitis or twin gestation affects these signatures. Study Design: Myometrial specimens were collected during cesarean delivery from the following 7 different groups of patients: term not in labor (n=31), term labor (n=13), preterm not in labor (n=21), preterm labor with acute clinical chorioamnionitis (n=6), preterm labor with no acute clinical chorioamnionitis (n=9), twin preterm not in labor (n=8), and twin preterm labor with no acute clinical chorioamnionitis (n=5). RNA was extracted, reverse transcribed and quantitative polymerase chain reactions were performed on 44 candidate genes (with evidence for differential expression in human term labor) using the Fluidigm platform. Computational analysis was performed using 2-class unpaired Wilcoxon tests and principal component analysis. Results: Computational analysis revealed that gene expression in the preterm myometrium, irrespective of whether in labor or not in labor, clustered tightly and is clearly different from the term labor and term not-in-labor groups. This was true for both singleton and twin pregnancies. Principal component analysis showed that 57% of the variation was explained by 3 principal components. These 44 genes interact in themes of prostaglandin activity and inflammatory signaling known to be important during term labor, but are not a full representation of the myometrium transcriptional activity. Conclusion: The myometrial contractions associated with preterm labor are associated with a pattern of gene expression that is distinct from term labor. Therefore, preterm labor may be initiated by a different myometrial process or processes outside the myometrium.

DOI 10.1016/j.ajog.2021.07.002
Citations Scopus - 9Web of Science - 7
Co-authors Craig Pennell, Roger Smith, Carlos Riveros
2022 Heslop B, Bailey K, Stojanovski E, Paul J, Drew A, 'Anthropological Prosociality via Sub-Group Level Selection', Integrative Psychological and Behavioral Science, 56 180-205 (2022) [C1]

A perennial challenge of evolutionary psychology is explaining prosocial traits such as a preference for fairness rather than inequality, compassion towards suffering, and an inst... [more]

A perennial challenge of evolutionary psychology is explaining prosocial traits such as a preference for fairness rather than inequality, compassion towards suffering, and an instinctive ability to coordinate within small teams. Considering recent fossil evidence¿and a novel logical test, we deem present explanations insufficiently explanatory of the divergence of hominins. In answering this question, we focus on the divergence of hominins from the last common ancestor (LCA) shared with Pan. We consider recent fossil discoveries that indicate the LCA was bipedal, which reduces the cogency of this explanation for hominin development. We also review evolutionary theory that claims to explain how hominins developed into modern humans, however it is found that no mechanism differentiates hominins from other primates. Either the mechanism was available to the last common ancestor (LCA) (with P. troglodytes as its proxy), or because early hominins had insufficient cognition to utilise the mechanism. A novel mechanism, sub-group level selection (sGLS) is hypothesised by triangulating two pieces of data rarely considered by evolutionary biologists. These are behavioural dimorphism of Pan (chimpanzees and bonobos) that remain identifiable in modern humans, and the social behaviour of primate troops in a savannah ecology. We then contend that sGLS supplied an exponential effect which was available to LCA who left the forest, but was not sufficiently available to any other primates. In conclusion, while¿only indirectly supported by various¿evidence,¿sGLS is found to be¿singularly and persuasively explanatory¿of human's unique evolutionary story.

DOI 10.1007/s12124-021-09606-y
Citations Scopus - 2Web of Science - 1
Co-authors Elizabeth Stojanovski
2021 Ilicic M, Zakar T, Gregson A, Hussein WM, Smith R, Paul JW, 'Histone Deacetylase Inhibitors: Providing New Insights and Therapeutic Avenues for Unlocking Human Birth', REPRODUCTIVE SCIENCES, 29 3134-3146 (2021) [C1]
DOI 10.1007/s43032-021-00778-x
Citations Scopus - 2Web of Science - 1
Co-authors Marina Paul, Roger Smith
2021 Coler BS, Shynlova O, Boros-Rausch A, Lye S, McCartney S, Leimert KB, et al., 'Landscape of Preterm Birth Therapeutics and a Path Forward', JOURNAL OF CLINICAL MEDICINE, 10 (2021) [C1]
DOI 10.3390/jcm10132912
Citations Scopus - 23Web of Science - 9
Co-authors Roger Smith
2020 Paul JW, Kemsley JO, Butler TA, Tolosa JM, Thompson MB, Smith R, Whittington CM, 'A comparison of uterine contractile responsiveness to arginine vasopressin in oviparous and viviparous lizards', Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology, 190 49-62 (2020) [C1]

Nonapeptides and their receptors regulate a diverse range of physiological processes. We assessed the contractile responsiveness of uteri from the squamate viviparous-oviparous sp... [more]

Nonapeptides and their receptors regulate a diverse range of physiological processes. We assessed the contractile responsiveness of uteri from the squamate viviparous-oviparous species pair, Pseudemoia entrecasteauxii and Lampropholis guichenoti, as well as the bimodally reproductive species, Saiphos equalis, to arginine vasopressin (AVP). We assessed the resulting uterine contractility as a function of pregnancy status, species and parity mode. We also measured mRNA abundance for the nonapeptide receptor, oxytocin receptor (oxtr), in uteri from P. entrecasteauxii and L. guichenoti and compared expression across pregnancy status and parity mode. We found that pregnant uteri exhibited a significantly greater contractile response to AVP than non-pregnant uteri in all three lizard species studied. Cross-species comparisons revealed that uteri from viviparous P. entrecasteauxii were significantly more responsive to AVP than uteri from oviparous L. guichenoti during both pregnant and non-pregnant states. Conversely, for non-pregnant S. equalis, uteri from viviparous individuals were significantly less responsive to AVP than uteri from oviparous individuals, while during pregnancy, there was no difference in AVP contractile responsiveness. There was no difference in expression of oxtr between L. guichenoti and P. entrecasteauxii, or between pregnant and non-pregnant individuals within each species. We found no significant correlation between oxtr expression and AVP contractile responsiveness. These findings indicate that there are differences in nonapeptide signalling across parity mode and suggest that in these lizards, labour may be triggered either by an increase in plasma nonapeptide concentration, or by an increase in expression of a different nonapeptide receptor from the vasopressin-like receptor family.

DOI 10.1007/s00360-019-01254-4
Citations Scopus - 6Web of Science - 5
Co-authors Roger Smith
2020 Smith R, Paul JW, Tolosa JM, 'Sharpey-Schafer Lecture 2019: From retroviruses to human birth', Experimental Physiology, 105 555-561 (2020) [C1]

New Findings: What is the topic of this review? The timing of birth is an important determinant of future health and well-being. This review examines the role of endogenous retrov... [more]

New Findings: What is the topic of this review? The timing of birth is an important determinant of future health and well-being. This review examines the role of endogenous retroviruses as upstream regulators of key biological functions of the placenta, including cell-cell fusion, modulation of the maternal immune system, and the production of key pregnancy hormones. What advances does it highlight? Endogenous retroviruses are an obligate requirement for successful human reproduction. The products of retroviral elements, incorporated into the germline millions of years ago, have been co-opted to serve vital biological roles within the placenta that ultimately dictate the length of human pregnancy and therefore well-being trajectories. Abstract: Gestational length at the time of birth is an important determinant of future health and well-being, yet the physiological regulation of the onset of labour in humans remains obscure. The evolution of egg formation and internal fertilisation in amniotes required a mechanism to suppress the contractile activity of the oviduct that is provided by progesterone. Delivery of the egg is then associated with the withdrawal of progesterone and a return of contractile activity to the reproductive tract. In mammals, the process of pregnancy is complicated further by the need to protect the fetus from potential attack by the maternal immune system. There is increasing evidence that retroviruses incorporated into the mammalian germline in the evolutionary past play a key role in suppressing the maternal immune reaction to the developing conceptus, organising the development of the placenta and perhaps, in humans, modulating the action of progesterone, determining gestational length and the onset of labour. It seems that the presence of an endogenous retrovirus is an obligate requirement for human reproduction.

DOI 10.1113/EP088155
Citations Scopus - 4Web of Science - 4
Co-authors Roger Smith
2020 Butler TA, Paul JW, Smith R, 'Non-conventional signalling in human myometrium by conventional pathways: looking back for a synergistic future', Current Opinion in Physiology, 13 145-154 (2020) [C1]

The mechanisms that bring about the onset of labor in humans remain poorly understood. Previous research has extensively explored signalling pathways that maintain myometrial rela... [more]

The mechanisms that bring about the onset of labor in humans remain poorly understood. Previous research has extensively explored signalling pathways that maintain myometrial relaxation and identified roles for key molecules, including cyclic nucleotides, nitric oxide, carbon monoxide, hydrogen sulfide and progesterone. However, these conventional pro-relaxation signalling pathways have fallen out of favor to inflammatory signalling, which is now widely regarded as an instigator of myometrial transformation toward a contractile phenotype and initiator of labor. This article revisits the complex inter-play of conventional pro-relaxation signalling, and explores the concept that progesterone, cAMP, glucocorticoids, and possibly gasotransmitters, work in synergy to constitute a uterine brake that suspends the intrinsic contractility of the myometrium, thus enabling retention of the conceptus and the progression of pregnancy. As term approaches, this uterine brake of relaxatory signalling is ultimately withdrawn, thus permitting restoration of myometrial contractility and culminating in the initiation of labor.

DOI 10.1016/j.cophys.2019.11.010
Citations Scopus - 4Web of Science - 3
Co-authors Roger Smith
2020 Zakar T, Paul JW, 'Fetal Membrane Epigenetics', FRONTIERS IN PHYSIOLOGY, 11 (2020) [C1]
DOI 10.3389/fphys.2020.588539
Citations Scopus - 4Web of Science - 2
2020 Ilicic M, Zakar T, Paul J, 'The Regulation of Uterine Function During Parturition: An Update and Recent Advances', Reproductive Sciences, 27 3-28 (2020) [C1]
DOI 10.1007/s43032-019-00001-y
Citations Scopus - 17Web of Science - 8
Co-authors Marina Paul
2020 Rowe CW, Dill T, Griffin N, Jobling P, Faulkner S, Paul JW, et al., 'Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion', Scientific Reports, 10 (2020) [C1]
DOI 10.1038/s41598-020-58425-5
Citations Scopus - 28Web of Science - 17
Co-authors Roger Smith, Sam Faulkner, Christopher W Rowe, Phillip Jobling, Hubert Hondermarck
2019 Rowe CW, Faulkner S, Paul JW, Tolosa JM, Gedye C, Bendinelli C, et al., 'The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis.', BMC endocrine disorders, 19 128 (2019) [C1]
DOI 10.1186/s12902-019-0457-1
Citations Scopus - 2Web of Science - 2
Co-authors Christopher W Rowe, Cino Bendinelli, Hubert Hondermarck, Sam Faulkner, John Attia, Roger Smith, Katie-Jane Wynne
2019 Rowe CW, Dill T, Faulkner S, Gedye C, Paul JW, Tolosa JM, et al., 'The precursor for nerve growth factor (ProNGF) in thyroid cancer lymph node metastases: Correlation with primary tumour and pathological variables', International Journal of Molecular Sciences, 20 1-13 (2019) [C1]
DOI 10.3390/ijms20235924
Citations Scopus - 4Web of Science - 2
Co-authors Sam Faulkner, Hubert Hondermarck, Christopher W Rowe, Mark Jones, Roger Smith
2019 Ilicic M, Zakar T, Paul JW, 'Epigenetic regulation of progesterone receptors and the onset of labour', Reproduction, Fertility and Development, 31 1035-1048 (2019) [C1]

Progesterone plays a crucial role in maintaining pregnancy by promoting myometrial quiescence. The withdrawal of progesterone action signals the end of pregnancy and, in most mamm... [more]

Progesterone plays a crucial role in maintaining pregnancy by promoting myometrial quiescence. The withdrawal of progesterone action signals the end of pregnancy and, in most mammalian species, this is achieved by a rapid fall in progesterone concentrations. However, in humans circulating progesterone concentrations remain high up to and during labour. Efforts to understand this phenomenon led to the 'functional progesterone withdrawal' hypothesis, whereby the pro-gestation actions of progesterone are withdrawn, despite circulating concentrations remaining elevated. The exact mechanism of functional progesterone withdrawal is still unclear and in recent years has been the focus of intense research. Emerging evidence now indicates that epigenetic regulation of progesterone receptor isoform expression may be the crucial mechanism by which functional progesterone withdrawal is achieved, effectively precipitating human labour despite high concentrations of circulating progesterone. This review examines current evidence that epigenetic mechanisms play a role in determining whether the pro-gestation or pro-contractile isoform of the progesterone receptor is expressed in the pregnant human uterus. We explore the mechanism by which these epigenetic modifications are achieved and, importantly, how these underlying epigenetic mechanisms are influenced by known regulators of uterine physiology, such as prostaglandins and oestrogens, in order to phenotypically transform the pregnant uterus and initiate labour.

DOI 10.1071/RD18392
Citations Scopus - 7Web of Science - 7
Co-authors Marina Paul
2019 Butler T, Paul J, Chan E-C, Smith R, Tolosa Gonzalez JM, 'Misleading Westerns: Common Quantification Mistakes in Western Blot Densitometry and Proposed Corrective Measures', BioMed Research International, 2019 (2019) [C1]
DOI 10.1155/2019/5214821
Citations Scopus - 53Web of Science - 42
Co-authors Roger Smith
2018 Paul JW, Smith R, 'Preventing Preterm Birth: New Approaches to Labour Therapeutics using Nanoparticles', BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 52 48-59 (2018) [C1]
DOI 10.1016/j.bpobgyn.2018.03.005
Citations Scopus - 5Web of Science - 4
Co-authors Roger Smith
2018 Heslop B, Drew A, Stojanovski E, Bailey K, Paul JW, 'Collaboration Vouchers: A Policy to Increase Population Wellbeing', Societies, 8 (2018) [C1]
DOI 10.3390/soc8020037
Citations Scopus - 2Web of Science - 1
Co-authors Elizabeth Stojanovski
2018 Heslop B, Bailey K, Paul JW, Stojanovski E, 'The PILAR Model as a Measure of Peer Ratings of Collaboration Viability in Small Groups', Social Sciences, 7 1-14 (2018) [C1]
DOI 10.3390/socsci7030049
Co-authors Elizabeth Stojanovski
2018 Heslop B, Paul J, Stojanovski E, Bailey K, 'Organisational Psychology and Appreciative Inquiry: Unifying the Empirical and the Mystical', AI Practitioner, 20 69-90 (2018) [C1]
DOI 10.12781/978-1-907549-34-2-11
Co-authors Elizabeth Stojanovski
2018 Heslop B, Stojanovski E, Paul JW, Bailey K, 'PILAR: A Model of Collaboration to Encapsulate Social Psychology', Review of General Psychology, 22 321-333 (2018) [C1]
DOI 10.1037/gpr0000141
Citations Scopus - 8Web of Science - 6
Co-authors Elizabeth Stojanovski
2018 Heslop B, Stojanovski E, Iverson S, Paul JW, Bailey K, 'Respondent disengagement from a peer assessment instrument measuring Collaboration Viability', Australasian Journal of Engineering Education, 22 95-106 (2018) [C1]
DOI 10.1080/22054952.2018.1437676
Co-authors Elizabeth Stojanovski
2017 Ilicic M, Butler T, Zakar T, Paul JW, 'The expression of genes involved in myometrial contractility changes during ex situ culture of pregnant human uterine smooth muscle tissue', Journal of Smooth Muscle Research, 53 73-89 (2017) [C1]

Background: Ex situ a nalyses of human myometrial t issue h as b een u sed t o i nvestigate t he r egulation of uterine quiescence and transition to a contractile phenotype. Follo... [more]

Background: Ex situ a nalyses of human myometrial t issue h as b een u sed t o i nvestigate t he r egulation of uterine quiescence and transition to a contractile phenotype. Following concerns about the validity of cultured primary cells, we examined whether myometrial tissue undergoes culture-induced changes ex situ that may affect the validity of in vitro models. Objectives: To determine whether human myometrial tissue undergoes culture-induced changes ex situ in Estrogen receptor 1 (ESR1), Prostaglandin-endoperoxide synthase 2 (PTGS2) and Oxytocin receptor (OXTR) expression. Additionally, to determine whether culture conditions approaching the in vivo environment influence the expression of these key genes. Methods: Term non-laboring human myometrial tissues were cultured in the presence of specific treatments, including; serum supplementation, progesterone and estrogen, cAMP, PMA, stretch or NF-¿B inhibitors. ESR1, PTGS2 and OXTR mRNA abundance after 48 h culture was determined using quantitative RT-PCR. Results: Myometrial tissue in culture exhibited culture-induced up-regulation of ESR1 and PTGS2 and down-regulation of OXTR mRNA expression. Progesterone prevented culture-induced increase in ESR1 expression. Estrogen further up-regulated PTGS2 expression. Stretch had no direct effect, but blocked the effects of progesterone and estrogen on ESR1 and PTGS2 expression. cAMP had no effect whereas PMA further up-regulated PTGS2 expression and prevented decline of OXTR expression. Conclusion: Human myometrial tissue in culture undergoes culture-induced gene expression changes consistent with transition toward a laboring phenotype. Changes in ESR1, PTGS2 and OXTR expression could not be controlled simultaneously. Until optimal culture conditions are determined, results of in vitro experiments with myometrial tissues should be interpreted with caution.

DOI 10.1540/jsmr.53.73
Citations Scopus - 11
Co-authors Marina Paul
2017 Rowe CW, Paul JW, Gedye C, Tolosa JM, Bendinelli C, McGrath S, Smith R, 'Targeting the TSH receptor in thyroid cancer', Endocrine-Related Cancer, 24 R191-R202 (2017) [C1]

Recent advances in the arena of theranostics have necessitated a re-examining of previously established fields. The existing paradigm of therapeutic thyroid-stimulating hormone re... [more]

Recent advances in the arena of theranostics have necessitated a re-examining of previously established fields. The existing paradigm of therapeutic thyroid-stimulating hormone receptor (TSHR) targeting in the post-surgical management of differentiated thyroid cancer using levothyroxine and recombinant human thyroid-stimulating hormone (TSH) is well understood. However, in an era of personalized medicine, and with an increasing awareness of the risk profile of longstanding pharmacological hyperthyroidism, it is imperative clinicians understand the molecular basis and magnitude of benefit for individual patients. Furthermore, TSHR has been recently re-conceived as a selective target for residual metastatic thyroid cancer, with pilot data demonstrating effective targeting of nanoparticles to thyroid cancers using this receptor as a target. This review examines the evidence for TSHR signaling as an oncogenic pathway and assesses the evidence for ongoing TSHR expression in thyroid cancer metastases. Priorities for further research are highlighted.

DOI 10.1530/ERC-17-0010
Citations Scopus - 45Web of Science - 38
Co-authors Roger Smith, Christopher W Rowe, Cino Bendinelli
2017 Ilicic M, Zakar T, Paul JW, 'Modulation of Progesterone Receptor Isoform Expression in Pregnant Human Myometrium', BIOMED RESEARCH INTERNATIONAL, 2017 (2017) [C1]
DOI 10.1155/2017/4589214
Citations Scopus - 17Web of Science - 12
Co-authors Marina Paul
2017 Paul JW, Hua S, Ilicic M, Tolosa JM, Butler T, Robertson S, Smith R, 'Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor', AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 216 (2017) [C1]
DOI 10.1016/j.ajog.2016.08.027
Citations Scopus - 70Web of Science - 48
Co-authors Marina Paul, Roger Smith, Susan Hua
2017 Heslop B, Stojanovski E, Paul J, Bailey K, 'Are We Collaborating Yet? Employee Assessment of Peer s Perceptions', International Journal of Human Resource Studies, 7 175-175 [C1]
DOI 10.5296/ijhrs.v7i4.11818
Co-authors Elizabeth Stojanovski
2017 Heidari Kani M, Chan EC, Young RC, Butler T, Smith R, Paul JW, '3D Cell Culturing and Possibilities for Myometrial Tissue Engineering', Annals of Biomedical Engineering, 45 1746-1757 (2017) [C1]

Research insights into uterine function and the mechanisms of labour have been hindered by the lack of suitable animal and cellular models. The use of traditional culturing method... [more]

Research insights into uterine function and the mechanisms of labour have been hindered by the lack of suitable animal and cellular models. The use of traditional culturing methods limits the exploration of complex uterine functions, such as cell interactions, connectivity and contractile behaviour, as it fails to mimic the three-dimensional (3D) nature of uterine cell interactions in vivo. Animal models are an option, however, use of these models is constrained by ethical considerations as well as translational limitations to humans. Evidence indicates that these limitations can be overcome by using 3D culture systems, or 3D Bioprinters, to model the in vivo cytological architecture of the tissue in an in vitro environment. 3D cultured or 3D printed cells can be used to form an artificial tissue. This artificial tissue can not only be used as an appropriate model in which to study cellular function and organisation, but could also be used for regenerative medicine purposes including organ or tissue transplantation, organ donation and obstetric care. The current review describes recent developments in cell culture that can facilitate the development of myometrial 3D structures and tissue engineering applications.

DOI 10.1007/s10439-016-1749-5
Citations Scopus - 12Web of Science - 12
Co-authors Roger Smith
2017 W Paul J, 'Expression of KCNH2 (hERG1) and KCNE2 Correlates With Expression of Key Myometrial Genes in Term Pregnant Human Myometrium', Human Endocrinology, 2 1-7
DOI 10.24966/he-9640/100008
2017 Paul JW, ilicic M, zakar T, smith R, 'Expression of KCNH2 (hERG1) and KCNE2 Correlates With Expression of Key Myometrial Genes in Term Pregnant Human Myometrium', Journal of Human Endocrinology, 2 (2017) [C1]
DOI 10.24966/HHE-9640/10008
Co-authors Marina Paul, Roger Smith
2016 Heslop B, Bailey K, Paul JW, Drew AJ, Smith R, 'Collaboration Guidelines to Transform Culture', Interdisciplinary Journal of Partnership Studies, 3 1-25 (2016) [C1]
Co-authors Roger Smith
2015 Smith R, Imtiaz M, Banney D, Paul JW, Young RC, 'Why the heart is like an orchestra and the uterus is like a soccer crowd', AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 213 181-185 (2015) [C1]
DOI 10.1016/j.ajog.2015.06.040
Citations Scopus - 45Web of Science - 38
Co-authors Roger Smith
2015 Banney D, Young R, Paul JW, Imtiaz M, Smith R, 'A hypothesis for self-organization and symmetry reduction in the synchronization of organ-level contractions in the human uterus during labor', Symmetry, 7 1981-1988 (2015) [C1]

We present a hypothesis for a mechanism involving self-organization of small functional units that leads to organ-level synchronization of uterine contractions in human labor. Thi... [more]

We present a hypothesis for a mechanism involving self-organization of small functional units that leads to organ-level synchronization of uterine contractions in human labor. This view is in contrast to the long-held presumption that the synchronized behavior of the uterus is subject to well-defined internal organization (as is found in the heart) that exists prior to the onset of labor. The contractile units of the uterus are myocytes, which contract in response to both mechanical stretch and electrical stimulation. Throughout pregnancy progesterone maintains quiescence by suppression of "contraction-associated proteins" (CAPs). At the end of pregnancy a functional withdrawal of progesterone and an increasingly estrogenic environment leads to an increase in the production of CAPs. One CAP of particular importance is connexin 43, which creates gap junctions between the myocytes that cause them to become electrically coupled. The electrical connectivity between myocytes, combined with an increase in intrauterine pressure at the end of pregnancy shifts the uterus towards an increasingly unstable critical point, characterized by irregular, uncoordinated contractions. We propose that synchronous, coordinated contractions emerge from this critical point through a process of self-organization, and that the search for a uterine pacemaker has been unfruitful for the sole reason that it is non-existent.

DOI 10.3390/sym7041981
Citations Scopus - 5Web of Science - 5
Co-authors Roger Smith
2014 Parkington HC, Stevenson J, Tonta MA, Paul J, Butler T, Maiti K, et al., 'Diminished hERG K

Human ether-a-go-go-related gene (hERG) potassium channels determine cardiac action potential and contraction duration. Human uterine contractions are underpinned by an action pot... [more]

Human ether-a-go-go-related gene (hERG) potassium channels determine cardiac action potential and contraction duration. Human uterine contractions are underpinned by an action potential that also possesses an initial spike followed by prolonged depolarization. Here we show that hERG channel proteins (a-conducting and ßinhibitory subunits) and hERG currents exist in isolated patch-clamped human myometrial cells. We show that hERG channel activity suppresses contraction amplitude and duration before labour, thereby facilitating quiescence. During established labour, expression of ß-inhibitory protein is markedly enhanced, resulting in reduced hERG activity that is associated with an increased duration of uterine action potentials and contractions. Thus, changes in hERG channel activity contribute to electrophysiological mechanisms that produce contractions during labour. We also demonstrate that this system fails in women with elevated BMI, who have enhanced hERG activity as a result of low ß-inhibitory protein expression, which likely contributes to the weak contractions and poor labour outcomes observed in many obese women necessitating caesarean delivery. © 2014 Macmillan Publishers Limited.

DOI 10.1038/ncomms5108
Citations Scopus - 44Web of Science - 35
Co-authors Roger Smith
2013 Butler T, Paul J, Europe-Finner N, Smith R, Chan E-C, 'Role of serine-threonine phosphoprotein phosphatases in smooth muscle contractility', AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 304 C485-C504 (2013) [C1]
DOI 10.1152/ajpcell.00161.2012
Citations Scopus - 43Web of Science - 29
Co-authors Roger Smith
2012 Smith R, Paul JW, Maiti K, Tolosa Gonzalez JM, Madsen GM, 'Recent advances in understanding the endocrinology of human birth', Trends in Endocrinology & Metabolism, 23 516-523 (2012) [C1]
Citations Scopus - 27Web of Science - 22
Co-authors Roger Smith
2012 Hure AJ, Collins CE, Giles WB, Paul JW, Smith R, 'Greater maternal weight gain during pregnancy predicts a large but lean fetal phenotype: A prospective cohort study', Maternal and Child Health Journal, 16 1374-1384 (2012) [C1]
DOI 10.1007/s10995-011-0904-8
Citations Scopus - 22Web of Science - 21
Co-authors Roger Smith, Alexis Hure, Clare Collins
2012 Welsh T, Paul J, Palliser H, Hirst J, Mesiano S, Zakar T, 'PGDH Expression Decreases at Term before Labor Onset in Guinea Pig Fetal Membranes', REPRODUCTIVE SCIENCES, 19 192A-192A (2012) [C3]
Co-authors Jon Hirst, Hannah Palliser
2012 Welsh TN, Paul JW, Palliser HK, Tabatabaeehatambakhsh SH, Hirst JJ, Mesiano S, Zakar T, '15-hydroxyprostaglandin dehydrogenase expression and localization in guinea pig gestational tissues during late pregnancy and parturition', Reproductive Sciences, 19 1099-1109 (2012) [C1]
DOI 10.1177/1933719112442247
Citations Scopus - 3Web of Science - 3
Co-authors Jon Hirst, Hannah Palliser
2011 Paul JW, Maiti K, Read MA, Hure AJ, Smith JI, Chan EC, Smith R, 'Phasic phosphorylation of caldesmon and ERK 1/2 during contractions in human myometrium', PLoS ONE, 6 1-7 (2011) [C1]
DOI 10.1371/journal.pone.0021542
Citations Scopus - 26Web of Science - 23
Co-authors Roger Smith, Alexis Hure
2011 Maiti K, Paul JW, Read MA, Chan EC, Riley SC, Nahar P, Smith R, 'G-1-activated membrane estrogen receptors mediate increased contractility of the human myometrium', Endocrinology, 152 2448-2455 (2011) [C1]
DOI 10.1210/en.2010-0979
Citations Scopus - 53Web of Science - 46
Co-authors Roger Smith
2005 Nixon B, Paul JW, Spiller CM, Attwell-Heap AG, Ashman LK, Aitken RJ, 'Evidence for the involvement of PECAM-1 in a receptor mediated signal-transduction pathway regulating capacitation-associated tyrosine phosphorylation in human spermatozoa', Journal of Cell Science, 118 4865-4877 (2005) [C1]
DOI 10.1242/jcs.02604
Citations Scopus - 18Web of Science - 18
Co-authors John Aitken, Brett Nixon, Leonie Ashman
Show 43 more journal articles

Conference (41 outputs)

Year Citation Altmetrics Link
2023 Paredes Barreda A, Paul M, Zakar T, Amy G, Hussein W, Walker F, et al., 'Pro-Relaxation of Myometrial Phosphodiesterase Expression by Histone Deacetylase Inhibitors', Brisbane (2023)
Co-authors Rohan Walker, Roger Smith, Marina Paul
2023 Paul M, Zakar T, Phung J, Gregson A, Paredes Barreda A, Butler T, et al., '20alpha-Hydroxysteroid Dehydrogenase Expression in the Human Myometrium at Term and Preterm Birth: Relationship to Fetal Sex and Maternal Body Mass Index', Brisbane (2023)
Co-authors Rohan Walker, Roger Smith, Marina Paul, Craig Pennell
2023 Paul M, Paul JW, Hinwood M, Martin K, Hood R, Johnson S, et al., 'Clopidogrel inhibition of microglial chemotaxis impairs cognitive recovery post-stroke', Brisbane (2023)
Co-authors Rebecca Hood, Rohan Walker, Madeleine Hinwood, Marina Paul
2023 Paul M, Paul J, Hinwood M, Martin K, Hood R, Johnson S, et al., 'Clopidogrel Administration Impairs Post-Stoke Learning and Memory Recovery in Mice', Newcastle (2023)
Co-authors Madeleine Hinwood, Marina Paul, Michael Nilsson, Rebecca Hood, Rohan Walker
2023 Ilicic M, Zakar T, Phung J, Gregson A, Barreda AP, Butler TA, et al., 'Myometrial 20alpha-Hydroxysteroid Dehydrogenase Expression During Term & Preterm Birth: Relationship to Fetal Sex & Maternal BMI', REPRODUCTIVE SCIENCES, AUSTRALIA, Brisbane (2023)
Co-authors Marina Paul, Roger Smith, Craig Pennell
2023 Barau-Dalmau E, Butler T, Paul JW, Alpha G, Nahar P, Smith R, Tolosa JM, 'New Approach to the Targeted Delivery of Therapeutic Nanoparticles in Ovarian Cancer Using an Active Trans-Endothelial Transport Mechanism', REPRODUCTIVE SCIENCES, AUSTRALIA, Brisbane (2023)
Co-authors Roger Smith
2023 Paul M, Paul J, Hinwood M, Martin K, Hood R, Johnson S, et al., 'Clopidogrel Administration Impairs Post-Stoke Learning and Memory Recovery in Mice', Newcastle (2023)
Co-authors Rebecca Hood, Michael Nilsson, Madeleine Hinwood, Marina Paul
2022 Phung J, Wang CA, Reeders J, Zakar T, Paul JW, Pennell CE, et al., 'Preterm Labor with and without Chorioamnionitis is Associated with Activation of Myometrial Inflammatory Networks: A Comprehensive Transcriptomic Analysis', REPRODUCTIVE SCIENCES (2022)
Citations Web of Science - 1
Co-authors Craig Pennell, Roger Smith
2022 Ilicic M, Paul J, Hinwood M, Martin K, Hood R, Johnson S, et al., 'COGNITIVE IMPACTS OF ANTIPLATELETS USED FOR SECONDARY STROKE PREVENTION', INTERNATIONAL JOURNAL OF STROKE (2022)
Co-authors Rebecca Hood, Madeleine Hinwood, Marina Paul, Michael Nilsson, Rohan Walker
2021 Ilicic M, Paul JW, Hinwood M, Martin K, Hood RJ, Johnson SJ, et al., 'Antiplatelet medications and cognitive function: Do we have something to be worried about?', INTERNATIONAL JOURNAL OF STROKE (2021)
Co-authors Madeleine Hinwood, Michael Nilsson, Marina Paul, Rebecca Hood
2020 Paul J, 'On Target for Novel Therapies?', Vancouver, Canada (2020)
2019 Paul J, Hua S, Ilicic M, Tolosa Gonzalez JM, Butler T, Robertson S, Smith R, 'Preventing Preterm Birth: New Approaches to Labour Therapeutics using Nanoparticles', Las Vegas, NV, USA (2019)
Co-authors Roger Smith, Marina Paul, Susan Hua
2018 Rowe C, Dill T, Clarke M, Paul J, Gedye C, King S, Hondermarck H, 'A methodology for validating automated digital whole-slide analysis of immunohistochemical biomarkers using open source software (QuPath).', Newcastle, Australia (2018)
Co-authors Christopher W Rowe, Hubert Hondermarck
2018 Paul JW, Hua S, Ilicic M, Tolosa J, Butler T, Robertson S, Smith R, 'Targeted nanoparticles for next-generation therapeutic intervention during pregnancy', HMRI, Newcastle (2018)
Co-authors Susan Hua, Roger Smith, Marina Paul
2018 Rowe CW, Dill T, Faulkner S, Griffin N, Jobling P, King S, et al., 'Increased nerve density around papillary thyroid cancers and primary thyroid cancers with nodal metastases.', Adelaide (2018)
Co-authors Sam Faulkner, Christopher W Rowe, Roger Smith, Phillip Jobling, Hubert Hondermarck
2018 Paul J, Hua S, Ilicic M, Tolosa Gonzalez JM, Butler T, Robertson S, Smith R, 'A Spoonful of Nanoparticles Helps the Myometrium Calm Down', Park Hyatt, Melbourne, VIC, Australia (2018)
Co-authors Susan Hua, Marina Paul, Roger Smith
2018 Tolosa Gonzalez JM, Paul J, Paredes-Barreda A, Barau-Dalmau E, Butler T, Smith R, 'Application of microfluidic mixing technology for the production of oxytocin receptor-targeted immunoliposomes to achieve targeted drug delivery to the pregnant human uterus', Sydney, NSW, Australia (2018)
Co-authors Roger Smith
2018 Smith R, Paul J, Hua S, 'Nanoparticles to Prevent Preterm Labour', Newcastle, NSW, Australia (2018)
Co-authors Roger Smith, Susan Hua
2018 Rowe C, Dill T, King S, Gedye C, Paul J, Tolosa JM, Smith R, 'Thyroid cancers resected in patients with concurrent TSH-receptor stimulation have higher levels of sodium-iodide symporter (NIS) expression', CLINICAL ENDOCRINOLOGY, Perth, AUSTRALIA (2018)
Citations Web of Science - 1
Co-authors Roger Smith, Christopher W Rowe
2017 Rowe C, King S, Tolosa J, Paul J, Gedye C, Smith R, 'Overexpression of the Sodium-Iodide Symporter in thyroid cancer co-existing with Graves disease', Perth, Western Australia (2017)
Co-authors Roger Smith
2017 Paul JW, Hua S, Ilicic M, Tolosa J, Butler T, Robertson S, Smith R, 'Applying nanopharmacology to reproductive medicine: A novel targeted drug delivery system for the uterus', Perth, Western Australia (2017)
Co-authors Susan Hua, Roger Smith, Marina Paul
2017 Butler T, Heidari Kani M, Chan EC, Smith R, Paul JW, 'Evidence that MPRIP targets phosphatases and kinases to Myosin to regulate relaxation and contraction in the human myometrium', Evidence that MPRIP targets phosphatases and kinases to Myosin to regulate relaxation and contraction in the human myometrium, Orlando, FL., USA (2017)
Co-authors Roger Smith
2017 Heidari Kani M, Paul JW, Young RC, Chan EC, Smith R, 'Expression fingerprints of human primary myometrial, hTERT and PHM cells in comparison to term myometrium for myometrial tissue engineering', Orlando, FL., USA (2017)
Citations Web of Science - 1
Co-authors Roger Smith
2017 Rowe C, Tolosa Gonzalez JT, Faulkner S, Paul JW, Gedye C, McGrath S, et al., 'The precursor for nerve growth factor (proNGF) is detectable in the rinse of fine needle aspiration biopsy of thyroid cancer', Boston, Massachussetts (2017)
Co-authors Roger Smith, Hubert Hondermarck, Christopher W Rowe
2015 Paul J, Hua S, Smith R, 'A Targeted Drug Delivery System for the Uterus', REPRODUCTIVE SCIENCES (2015) [E3]
Citations Web of Science - 3
Co-authors Susan Hua, Roger Smith
2012 Parkington HC, Paul JW, Tonta MA, Chan EC, Sheehan PJ, Brennecke SP, et al., 'Human labour is associated with decreased myometrial ether-a-go-go related gene (hERG) potassium channels that modulate contractility', Proceedings of the 39th Annual Meeting of the Fetal and Neonatal Physiological Society, Zeist, The Netherlands (2012) [E3]
Co-authors Roger Smith
2012 Welsh TN, Paul JW, Palliser HK, Hirst JJ, Mesiano S, Zakar T, 'PGDH expression decreases at term before labor onset in guinea pig fetal membranes', Reproductive Sciences, San Diego, CA (2012) [E3]
Co-authors Hannah Palliser, Jon Hirst
2011 Hure AJ, Collins CE, Giles WB, Paul JW, Smith R, 'A large but lean fetal phenotype is associated with greater maternal weight gain during pregnancy', Obesity Research & Clinical Practice, Adelaide (2011) [E3]
Co-authors Clare Collins, Roger Smith, Alexis Hure
2011 Paul JW, Maiti K, Read MA, Hure AJ, Smith JI, Chan EC, Smith R, 'Studying laboring myometrium misses phosphorylation changes associated with contraction', Reproductive Sciences, Miami Beach (2011) [E3]
Co-authors Roger Smith, Alexis Hure
2010 Maiti K, Paul JW, Read MA, Chan EC, Smith R, 'Human labor Is associated with internalization and oligomerization of the membrane estrogen receptor, GPR30', Reproductive Sciences, Orlando, Florida (2010) [E3]
Co-authors Roger Smith
2010 Maiti K, Paul JW, Chan EC, Smith R, 'GPR30, the novel membrane estrogen receptor, stimulates contractility of myometrium by increasing expression of h-caldesmon', The Endocrine Society of Australia Annual Scientific Meeting Meeting Proceedings and Abstract Book, Sydney (2010) [E3]
Co-authors Roger Smith
2010 Paul JW, Maiti K, Read MA, Smith R, 'Caldesmon phosphorylation and phasic regulation of ERK 1/2 during contractions in human myometrium', The Endocrine Society of Australia Annual Scientific Meeting Proceedings and Abstract Book, Sydney (2010) [E3]
Co-authors Roger Smith
2009 Maiti K, Paul JW, Read MA, Chan EC, Smith R, 'Demonstration that activation of the cell surface estrogen receptor GPR30 causes phosphorylation of HSP27 and MAPK p42/44 in term human myometrial tissue and explants', Reproductive Sciences, Glasgow, Scotland (2009) [E3]
Co-authors Roger Smith
2009 Paul JW, Read MA, Smith R, 'Phosphorylation events associated with myometrial awakening and the development of contractile force in humans', Reproductive Sciences, Glasgow, Scotland (2009) [E3]
Co-authors Roger Smith
2008 Maiti K, Paul JW, Read MA, Chan EC, Smith R, 'Presence of the novel membrane estrogen receptor G-Protein coupled receptor 30 (GPR30) a membrane estrogen receptor in human pregnant myometrium and its biochemical characterization', 51st Annual Scientific Meeting of the Endocrine Society of Australia and Society of Reproductive Biology: Meeting Proceedings and Abstract Book, Melbourne, VIC (2008) [E3]
Co-authors Roger Smith
2008 Paul JW, Read MA, Chan EC, Smith R, 'Phospho-proteomic determination of contraction associated proteins in the human uterus', 51st Annual Scientific Meeting of the Endocrine Society of Australia and Society of Reproductive Biology: Meeting Proceedings and Abstract Book, Melbourne, VIC (2008) [E3]
Co-authors Roger Smith
2006 Paul JW, Aitken RJ, McLaughlin EA, 'Oolemmal Proteomics: Characterisation of Glycophosphatidylinositol Anchored Proteins Involved in Murine Fertilisation', Book of Abstracts, Lorne, Victoria, Australia (2006) [E3]
Co-authors John Aitken
2006 Nixon B, Paul JW, Spiller CM, Attwell-Heap AG, Aitken RJ, 'Evidence for the Involvement of Pecam-1 in a Reception Mediated Signal-Transduction Pathway regulating Capacitation-Associated Tyrosine Phosphorylation in Human Spermatozoa', Book of Abstracts, Lorne, Victoria, Australia (2006) [E3]
Co-authors John Aitken
2004 Paul JW, McLaughlin EA, Aitken RJ, 'Oolemmal Proteomics: Identification of the Oocyte Cell Surface Protein Complexes Involved in Sperm-egg Interaction', Reproduction, Fertility and Development, Sydney (2004) [E3]
Co-authors John Aitken
2003 Nixon B, Paul JW, Aitken RJ, 'Wheat germ agglutinin induced tyrosine phosphorylation of human spermatozoa', 28th Annual Lorne Conference on Protein Structure & Function, Lorne, Victoria (2003) [E3]
Co-authors John Aitken
2003 Nixon B, Attwell-Heap AG, Paul JW, Aitken RJ, 'Wheat Germ Agglutinin Induced Tyrosine Phosphorylation of Human Spermatozoa', Reproduction, Fertility and Development, Melbourne (2003) [E3]
Co-authors John Aitken
Show 38 more conferences

Report (1 outputs)

Year Citation Altmetrics Link
2017 Paul JW, Hua S, Ilicic M, Tolosa JM, Butler T, Robertson S, Smith R, 'Applying nanopharmacology to obstetrics: A novel targeted drug delivery system for the uterus', Atlas of Science, 1 (2017)
Co-authors Susan Hua, Roger Smith, Marina Paul
Edit

Grants and Funding

Summary

Number of grants 31
Total funding $4,411,691

Click on a grant title below to expand the full details for that specific grant.


20234 grants / $1,673,185

Is placental aging the key to understanding, predicting and preventing stillbirths?$1,125,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Laureate Professor Roger Smith, Doctor Jonathan Paul, Laureate Professor Roger Smith
Scheme Research Grant
Role Investigator
Funding Start 2023
Funding Finish 2027
GNo G2300697
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

Targeting Bromodomain and Extra-Terminal (BET) Proteins for Preventing Preterm Birth$538,020

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Doctor Jonathan Paul, Conjoint Professor Tamas Zakar, Doctor Carlos Riveros, Dr Mary Norris, Doctor Mary Norris, Mr Jason Phung
Scheme Ideas Grants
Role Lead
Funding Start 2023
Funding Finish 2025
GNo G2200411
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON Y

Combo Precellys Evolution and Cryolys Evolution with extra 7mL capacity rotor$5,175

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Doctor Jonathan Paul
Scheme Equipment Grant
Role Lead
Funding Start 2023
Funding Finish 2023
GNo G2301083
Type Of Funding Internal
Category INTE
UON Y

Preventing Preterm Birth: Elucidating the contraction-blocking effects of histone deacetylase inhibitors on global gene expression$4,990

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Doctor Jonathan Paul, Miss Anna Paredes Barreda, Conjoint Professor Tamas Zakar
Scheme Pilot Funding Scheme
Role Lead
Funding Start 2023
Funding Finish 2023
GNo G2300451
Type Of Funding Internal
Category INTE
UON Y

20221 grants / $742,094

Targeted Delivery of Nucleic Acid Therapeutics for Preventing Preterm Birth$742,094

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Doctor Jonathan Paul, Dr Waleed Hussein, Sonika Tyagi, Conjoint Professor Tamas Zakar
Scheme Ideas Grants
Role Lead
Funding Start 2022
Funding Finish 2024
GNo G2100572
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON Y

20212 grants / $393,460

Targeted Delivery of Nucleic Acid Therapeutics for Preventing Preterm Birth$375,278

Funding body: NSW Ministry of Health

Funding body NSW Ministry of Health
Project Team Doctor Jonathan Paul
Scheme Early-Mid Career Research Grant – Gene and Cell Therapy
Role Lead
Funding Start 2021
Funding Finish 2023
GNo G2100349
Type Of Funding C2400 – Aust StateTerritoryLocal – Other
Category 2400
UON Y

Development of Precision Medicine Tools for Improved Management of Preterm Birth Risks$18,182

Funding body: John Hunter Charitable Trust

Funding body John Hunter Charitable Trust
Project Team

Jonathan Paul, Craig Pennell, Bronwyn Andrew, Jason Phung

Scheme John Hunter Charitable Trust Grant
Role Lead
Funding Start 2021
Funding Finish 2021
GNo
Type Of Funding External
Category EXTE
UON N

20203 grants / $332,162

Development of Nanoliposome Targeting Technology$240,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Laureate Professor Roger Smith, Doctor Jonathan Paul
Scheme Research Grant
Role Investigator
Funding Start 2020
Funding Finish 2020
GNo G2000802
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

Targeted Delivery of Nucleic Acid Therapeutics for Preventing Preterm Birth$80,000

Funding body: NSW Ministry of Health

Funding body NSW Ministry of Health
Project Team Laureate Professor Roger Smith, Doctor Jonathan Paul, Doctor Jorge Tolosa Gonzalez, Miss Madeline King
Scheme Gene and Cell Therapy PhD Program
Role Investigator
Funding Start 2020
Funding Finish 2024
GNo G2000120
Type Of Funding C2300 – Aust StateTerritoryLocal – Own Purpose
Category 2300
UON Y

Assessment of Myometrial Transcriptome Changes Associated with Preterm Birth$12,162

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team

Jonathan Paul, Felicity Park, Craig Pennell, Bronwyn Andrew, Jason Phung

Scheme Research Grant
Role Lead
Funding Start 2020
Funding Finish 2020
GNo
Type Of Funding External
Category EXTE
UON N

20195 grants / $575,264

Uterine-Targeted Delivery of Dual Action Therapy for Preventing Preterm Birth$475,009

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Doctor Jonathan Paul, Conjoint Professor Tamas Zakar, Dr Waleed Hussein
Scheme Project Grant
Role Lead
Funding Start 2019
Funding Finish 2021
GNo G1800369
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON Y

The Applied Biosystems QuantStudio 6 Flex Real-Time PCR System$53,672

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Kirsty Pringle, Professor Simon Keely, Doctor Hannah Palliser, Doctor Jonathan Paul, Doctor Marina Paul, Doctor Lucy Murtha
Scheme Equipment Grant
Role Investigator
Funding Start 2019
Funding Finish 2019
GNo G1900306
Type Of Funding Scheme excluded from IGS
Category EXCL
UON Y

Olympus BX53-P Polarising Microscope$16,951

Funding body: Universityof Newcastle Faulty of Health and Medicine

Funding body Universityof Newcastle Faulty of Health and Medicine
Project Team

Lucy Murtha, Michael Schuliga, Marina Ilicic, Jonathan Paul

Scheme Equipment Grant
Role Investigator
Funding Start 2019
Funding Finish 2021
GNo
Type Of Funding Internal
Category INTE
UON N

Nikon DS-Qi2 Monochrome Camera Microscope Upgrade Package $15,675

Funding body: Faculty of Health and Medicine, The University of Newcastle

Funding body Faculty of Health and Medicine, The University of Newcastle
Project Team

Jonathan Paul, Trent Butler, Marina Ilicic, Jorge Tolosa, Kaushik Maiti, Kirsty Pringle, Julia Shaw, Hannah Palliser, Rohan Walker, Kirsten Coupland, Lucy Murtha, Mark Bigland, Andrew Boyle

Scheme Equipment grant
Role Lead
Funding Start 2019
Funding Finish 2020
GNo
Type Of Funding Internal
Category INTE
UON N

IncuSafe MCO-5M Automatic Air Jacket Multigas Incubator$13,957

Funding body: Faculty of Health and Medicine, The University of Newcastle

Funding body Faculty of Health and Medicine, The University of Newcastle
Project Team

Jacinta Martin, Sarah Delforce, Kirsty Pringle, Saije Morosin, Sonia Tamanna, Alyssa Lochrin, Celine Lees, Jason Phung, Trent Butler Jonathan Paul, Bridie Goggins, Rebecca Hood, Marina Ilicic

Scheme Equipment grant
Role Investigator
Funding Start 2019
Funding Finish 2020
GNo
Type Of Funding Internal
Category INTE
UON N

20182 grants / $21,267

Preventing Placental Aging and Stillbirth in a Pre-Clinical Model$17,307


Funding body: John Hunter Charitable Trust

Funding body John Hunter Charitable Trust
Project Team

Jonathan Paul, Bronwyn Andrew

Scheme Charitable trust grant
Role Lead
Funding Start 2018
Funding Finish 2018
GNo
Type Of Funding External
Category EXTE
UON N

HMRI Imaging Centre Pilot Grant round: A Targeted Drug Delivery System for the Uterus - MRI Characterisation of Nanoliposome Biodistribution$3,960

The Chancellor’s Award for Innovation provides funding to a University of Newcastle researcher or team who has made a discovery or innovation, which leads to, or potentially leads to, a commercial outcome. 

Funding body: Newcastle Innovation

Funding body Newcastle Innovation
Project Team

Jonathan Paul, Susan Hua, Roger Smith

Scheme Chancellor’s Award for Research Innovation
Role Lead
Funding Start 2018
Funding Finish 2018
GNo
Type Of Funding Internal
Category INTE
UON N

20174 grants / $404,380

Establishment of a Targeted Nanoparticle Development Facility at the Hunter Medical Research Institute$328,280

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Laureate Professor Roger Smith, Doctor Jonathan Paul
Scheme Project Grant
Role Investigator
Funding Start 2017
Funding Finish 2019
GNo G1701486
Type Of Funding C3200 – Aust Not-for Profit
Category 3200
UON Y

UON 2017 Researcher Equipment Grant $46,100

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Doctor Jonathan Paul
Scheme Researcher Equipment Grants
Role Lead
Funding Start 2017
Funding Finish 2017
GNo G1701158
Type Of Funding Internal
Category INTE
UON Y

A Targeted Drug Delivery System for the Uterus: Characterisation for Clinical Translation$20,000

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team

Dr. Jonathan W. Paul, Dr. Susan Hua, Dr. Bronwyn Andrew

Scheme Research Grant
Role Lead
Funding Start 2017
Funding Finish 2017
GNo
Type Of Funding External
Category EXTE
UON N

Understanding the myometrial transition at term and preterm labour to guide tocolysis$10,000

Funding body: Royal Australian and New Zealand College of Obstetricians and Gynaecologists

Funding body Royal Australian and New Zealand College of Obstetricians and Gynaecologists
Project Team Dr Jason Phung, Laureate Professor Roger Smith, Doctor Eng-Cheng Chan, Doctor Jonathan Paul, Conjoint Professor Tamas Zakar
Scheme NSW Regional Committee Training Research Grant
Role Investigator
Funding Start 2017
Funding Finish 2017
GNo G1701454
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

20161 grants / $21,745

Developing a Post-term Pregnancy Model to Study Placental Aging and Stillbirth$21,745

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Doctor Jonathan Paul, Dr Bronwyn Andrew
Scheme Research Grant
Role Lead
Funding Start 2016
Funding Finish 2016
GNo G1600377
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

20154 grants / $140,847

A safer way of treating premature labour and post-partum hemorrhage$65,625

Funding body: Seattle Children's Hospital Research Foundation

Funding body Seattle Children's Hospital Research Foundation
Project Team Laureate Professor Roger Smith, Associate Professor Susan Hua, Doctor Jonathan Paul
Scheme Research Grant
Role Investigator
Funding Start 2015
Funding Finish 2015
GNo G1501339
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Achieving Targeted Delivery of Drugs to Uterine Muscle in Women for the Prevention of Preterm Labour$48,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Jonathan Paul, Associate Professor Susan Hua, Laureate Professor Roger Smith
Scheme Project Grant
Role Lead
Funding Start 2015
Funding Finish 2016
GNo G1401504
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Developing a System for Targeting Drugs to Ovarian Cancer$25,222

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Doctor Jonathan Paul, Doctor Geoffrey Otton, Doctor John Bailey
Scheme Research Grant
Role Lead
Funding Start 2015
Funding Finish 2015
GNo G1501110
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

Society of Reproductive Investigation (SRI) 62nd Annual Scientific Meeting, San Francisco USA, 25-28 March 2015$2,000

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team Doctor Jonathan Paul
Scheme Travel Grant
Role Lead
Funding Start 2015
Funding Finish 2016
GNo G1500525
Type Of Funding Internal
Category INTE
UON Y

20121 grants / $34,454

Targeting the ether-a-go-go potassium channel as a treatment for post-partum heamorrhage$34,454

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Dr Andrew Carlin, Doctor Jonathan Paul
Scheme Research Grant
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1200956
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

20111 grants / $25,000

Role of the potassium channel hERG in regulating the onset of labor in humans$25,000

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Scheme Research Grant
Role Lead
Funding Start 2011
Funding Finish 2011
GNo
Type Of Funding Other Public Sector - State
Category 2OPS
UON N

20101 grants / $23,025

Identification of protein modifications associated with myometrial activation during the onset of labour$23,025

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Scheme Research Grant
Role Lead
Funding Start 2010
Funding Finish 2010
GNo
Type Of Funding Other Public Sector - State
Category 2OPS
UON N

20091 grants / $15,208

Apoptosis in pregnant human myometrium and its role in labour$15,208

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Doctor Kaushik Maiti, Doctor Jonathan Paul, Doctor Pravin Nahar
Scheme Research Grant
Role Investigator
Funding Start 2009
Funding Finish 2009
GNo G0189933
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

20081 grants / $9,600

LED fluorescence illuminators and filter set (525nm + 575DF20) for LAS3000 image analysis system$9,600

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Laureate Professor Roger Smith, Professor Ian Symonds, Conjoint Associate Professor Andrew Bisits, Conjoint Professor Tamas Zakar, Doctor John Fitter, Doctor Eng-Cheng Chan, Conjoint Associate Professor Rick Nicholson, Dr GIAVANNA Angeli, Doctor Kaushik Maiti, Doctor Jonathan Paul, Professor Jon Hirst, Doctor Hannah Palliser, Professor Eugenie Lumbers
Scheme Equipment Grant
Role Investigator
Funding Start 2008
Funding Finish 2008
GNo G0188543
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y
Edit

Research Supervision

Number of supervisions

Completed7
Current7

Current Supervision

Commenced Level of Study Research Title Program Supervisor Type
2023 PhD Illustrating the Role of Iron in the Development of Complex Life PhD (Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2023 PhD Synthesis and Functionalization of Bimodal Mesoporous Silica Nanoparticles for Ovarian Cancer Treatment PhD (Reproductive Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2023 PhD Communicating the Role of Molybdenum in Complex Life PhD (Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2022 PhD A Targeted Drug Delivery Strategy for Ovarian Cancer PhD (Reproductive Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2022 PhD Uterine-Targeted Delivery of Dual Action Therapy for Preventing Preterm Birth PhD (Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2021 PhD Targeted Delivery of Nucleic Acid Therapeutics for Preventing Preterm Birth PhD (Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2017 PhD Pathways to Uterine Activation at Labour PhD (Reproductive Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor

Past Supervision

Year Level of Study Research Title Program Supervisor Type
2023 PhD Preventing Preterm Birth: Next Generation Tocolytic Strategies for Inhibiting Pregnant Human Myometrial Contractility PhD (Reproductive Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2021 PhD A Consilience Model of Group Dynamics PhD (Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2020 PhD The Precursor for Nerve Growth Factor and Innervation in Thyroid Cancer PhD (Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2018 PhD Epigenetic Regulation of Progesterone Receptor Isoforms in Human Parturition PhD (Reproductive Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2018 PhD Exploring Novel Application of Tissue Engineering Strategies to Human Myometrium PhD (Reproductive Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2017 Honours Triggers of Amniote Labour Biological Sciences, The University of Sydney Co-Supervisor
2017 PhD Elucidating the Role of Myosin Phosphatase in the Contractility of Myometrial Smooth Muscle PhD (Reproductive Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
Edit

News

Spinal cord research

News • 15 Dec 2022

Spinal cord pain to PTSD: $5.2m in NHMRC grants to target pressing medical conditions

Both the body and the mind will be a key focus for innovative researchers from the University of Newcastle, who were successful in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants.

Pregnant woman

News • 8 Sep 2021

New study delivers answers about preterm labour

A team of researchers has discovered the process of labour during preterm birth is different from that of full-term birth.

Dr Jonathan Paul

News • 2 Sep 2016

Nanotech revolution for pregnancy drugs

A revolutionary method of delivering drugs specifically to the uterus, using antibody-coated nanoparticles, has been pioneered by researchers from the University of Newcastle (UON) and Hunter Medical Research Institute.

Dr Jonathan Paul

Position

Senior Research Fellow
Mothers and Babies Research Center
School of Medicine and Public Health
College of Health, Medicine and Wellbeing

Focus area

Reproductive Medicine

Contact Details

Email jonathan.paul@newcastle.edu.au
Phone (02) 4042 0348
Fax (02) 4042 0045

Office

Room Level 3, East
Building HMRI, John Hunter Hospital Campus
Location Callaghan
University Drive
Callaghan, NSW 2308
Australia
Edit